Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

statnews.com · 5 hours ago Biotech

Pharmalittle: We're reading about Chinese trial sites being probed, RFK Jr. and peptides, and more

Pharmalittle: We're reading about Chinese trial sites being probed, RFK Jr. and peptides, and more  statnews.com

#Clinical Trials

Seeking Alpha · 6 hours ago Biotech

Ligand Pharma (LGND): Bull Case Is A Biotech ARM, Bear Case Is Just Another Royalty Trust

Ligand Pharma (LGND): Bull Case Is A Biotech ARM, Bear Case Is Just Another Royalty Trust  Seeking Alpha

#Biotech Headlines

pharmaphorum · 6 hours ago Biotech

Drugmakers asked to defend Chinese trials; reports

Drugmakers asked to defend Chinese trials; reports  pharmaphorum

#Clinical Trials

The Clinical Trial Vanguard · 7 hours ago Biotech

Definium’s Phase 3 LSD Win Is Real. The Fracture It Exposed Is Bigger.

Definium’s Phase 3 LSD Win Is Real. The Fracture It Exposed Is Bigger.  The Clinical Trial Vanguard

#Clinical Trials

Business Wire · 7 hours ago Biotech

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder  Business Wire

#Clinical Trials

ICLG · 7 hours ago Biotech

Delaware court throws out biotech IPO derivative suit

Delaware court throws out biotech IPO derivative suit  ICLG

#Biotech Headlines